Home / World Marketplace / Archive by category Global Health & Biotech (Page 75)

Archive by category Global Health & Biotech

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award

WASHINGTON, April 19, 2024 (Korea Bizwire) – The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in the National Academy of Sciences building in Washington D.C. Klugman and [...]

Smith+Nephew Announces New Evidence Supporting ALLEVYN LIFE Foam Dressing’s Role in Pressure Injury Prevention

Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the [...]

Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules

Reminyl® is an established CNS brand for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer type The acquisition ensures continued access to this essential cholinesterase inhibitor for dementia patients in key markets Significant addition to Essential Pharma’s portfolio of specialty central nervous system (CNS) medicines and further expands the company’s presence [...]

Ascom Annual General Meeting Approves Increased Dividend Payout of CHF 0.30

Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, April 16, 2024 (Korea Bizwire) At the Annual General Meeting held in Zug on April 16, 2024, the shareholders of Ascom Holding AG approved all proposals of the Board of Directors by a large majority, except for the Remuneration Report. The Annual General Meeting was attended by [...]

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson & Johnson (J&J), will also join Recursion’s Board of Directors SALT LAKE CITY, April 16, 2024 (Korea Bizwire) – Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize [...]

Boehringer Ingelheim Reports Strong Growth in 2023 and Accelerates Late-stage Pipeline

Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV® Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launches R&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key [...]

London Research & Pharmaceuticals Presents the Advancement of LRP-661, Their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

LONDON, Ontario, April 15, 2024 (Korea Bizwire) – London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and predictable PK parameters. CBDS maintains improved oral formulation capabilities vs cannabidiol, including tablet and water-based solutions. When compared against the currently available oral solution [...]

Ascom Signed a 5-year Framework Contract with Istekki in Finland

Baar, Switzerland, April 11, 2024 (Korea Bizwire) – Ascom, a global leader in healthcare communication and workflow solutions, has signed a comprehensive framework agreement with Istekki, a significant Finnish healthcare organization. The 5-year agreement has an estimated volume of EUR 6 million and includes the installation of nurse call systems in acute and long-term care [...]

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia – Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid [...]

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

The Abdel-Mohsen lab findings shed light on how sugar molecules in the blood of people living with HIV may accelerate biological aging PHILADELPHIA, PA, April 10, 2024 (Korea Bizwire) – The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and [...]